Press Release & Publication

Press Release & Publication

Comparative physicochemical and structural characterisation studies establish high biosimilarity between BGL‑ASP and reference insulin aspart

Diabetes drug-maker USV marks entry into insulin with biosimilar of Insulin Aspart

USV Partners With Biogenomics To Launch INSUQUICK, The First Biosimilar Insulin Aspart for People with Diabetes In India

USV, Biogenomics launch INSUQUICK, biosimilar Insulin Aspart for diabetes treatment

USV partners with Biogenomics to launch biosimilar insulin aspart for diabetes in India

USV Partners With Biogenomics To Launch INSUQUICK, The First Biosimilar Insulin Aspart for People with Diabetes In India

USV partners with Biogenomics to launch first biosimilar Insulin Aspart for diabetics In India

USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India